ClinicalTrials.Veeva

Menu

Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Gallbladder Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT07092397
SMC-2022-03-136

Details and patient eligibility

About

This retrospective study aims to investigate the prognostic significance of artificial intelligence (AI)-powered analysis of tumor-infiltrating lymphocytes (TILs) and the tumor microenvironment (TME) in patients with resected gallbladder cancer. Using hematoxylin and eosin (H&E)-stained slides, the study quantifies spatial TME features, including TIL density, tertiary lymphoid structures, and fibroblast density, to identify potential TME-related risk factors associated with survival.

Enrollment

266 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who underwent curative surgery for gallbladder cancer.

Exclusion criteria

  • Patients who did not achieve R0 resection.
  • Patients with metastatic disease.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems